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Introduction: Pulmonary artery thrombosis is one of the most important complications in patients with nephrotic
syndrome. It is well known among nephrologists, however, that this possibly lethal complication very rarely occurs
before the diagnosis of nephrotic syndrome.
Case presentation: A 21-year-old Japanese woman who had no specific medical history consulted a primary care
clinic. Although she had been aware of the edema of her lower extremities for 2 weeks, her chief complaints were
palpitations and chest pain, which had started the day before. An electrocardiogram and chest radiograph did not
reveal any specific abnormalities. Because her etiology was not clear, she was referred to an emergency division in
a hospital 2 days later. Although arterial blood gas analysis did not reveal hypoxemia, computed tomography
revealed thrombi of the bilateral pulmonary arteries and left iliac vein. At this point, a laboratory examination
confirmed the diagnosis of nephrotic syndrome. Subsequently, she was admitted, and anticoagulant therapy was
initiated immediately. The next day, oral corticosteroid therapy was initiated, and an inferior vena cava filter was
placed internally. Her proteinuria resolved after 3 weeks of treatment. The prompt and complete response to
corticosteroid therapy suggested that minimal change disease was the etiology of the nephrotic syndrome and
pulmonary artery thrombosis.
Conclusions: An awareness regarding the complication of pulmonary artery thrombosis in nephrotic syndrome is
important not only for nephrologists but for all clinicians. Contrast-enhanced computed tomography is crucial to
detect pulmonary artery thrombosis.
Keywords: Nephrotic syndrome, ThromboembolismIntroduction
Thromboembolism is one of the major complications of
nephrotic syndrome (NS) [1]. In particular, pulmonary
artery thrombosis is serious and often fatal [2]. It is well
recognized among nephrologists, however, that this
potentially lethal complication of NS very rarely occurs
before the diagnosis of NS or that patients might not
consult a nephrologist for their symptoms [3-6].
Here, we describe the case of a 21-year-old Japanese
woman who had presented with pulmonary artery
thrombosis, and was subsequently diagnosed with NS.* Correspondence: iku621@yahoo.co.jp
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A 21-year-old Japanese woman who had no specific
medical history consulted a primary care clinic. Although
she had been aware of the edema of her lower extremities
for 2 weeks, her chief complaints were palpitations and
chest pain, which had started the day before. An elec-
trocardiogram (ECG) and chest radiograph did not reveal
any specific abnormality. The next day she consulted
another physician but her etiology was still not clear.
She was referred to the emergency division in a municipal
hospital 2 days later. Arterial blood gas analysis did not
reveal hypoxemia. However, computed tomography (CT)
revealed thrombi in her bilateral pulmonary arteries and
left iliac vein, and a laboratory examination revealed NS.
She was admitted and anticoagulant therapy was initiated
immediately. The next day she was referred to a nephrolo-
gist at our university hospital.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
AB
Figure 1 Computed tomography angiogram showing thrombi
(arrows) in the pulmonary trunk, bilateral pulmonary artery (A)
and left common iliac vein (B).
Figure 2 Computed tomography taken at day 14 showing
capture of thrombi in the inferior vena cava filter (arrow).
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is a nonsmoker and not obese. She has never taken a
contraceptive pill. On admission, her physical charac-
teristics were: weight 53kg; height 166cm; body mass
index 19.2kg/m2; blood pressure 110/62mmHg; pulse
rate 120 beats/minute; respiratory rate 20 breaths/minute
and saturation of peripheral oxygen (pulse oximetry)
97% (room air). Her physical examination was normal
except for the edema of the lower extremities. The
laboratory investigation data were as follows: leukocyte
9660 cells/μL; hemoglobin 14.8g/dL; platelets 329,000/μL;
hematocrit 42.2%; blood urea nitrogen 19mg/dL; se-
rum creatinine 1.26mg/dL; serum albumin 1.7g/dL; total
protein 4.3g/dL; total cholesterol 497mg/dL; triglyceride
187mg/dL; the levels of serum complement C3 were
116mg/dL and C4 34mg/dL. Serum antinuclear antibody
was negative. The coagulation profile revealed the fol-
lowing: prothrombin time 15.2 seconds; activated partial
thromboplastin time (APTT) 84.5 seconds; D-dimer
6.9μg/mL (normal: 0 to 0.4μg/mL); fibrinogen 832mg/mL
(normal: 150 to 410mg/mL); fibrin-fibrinogen degradation
product 10.5μg/dL (normal: 0 to 5μg/dL); antithrombin
III 70% (normal: 80% to 120%); protein C 29% (normal:
70% to 140%); and protein S 66% (normal: 65% to 135%).
Urinary protein excretion was 14g/g creatinine, and
microhematuria was absent. In addition, arterial blood
gas analysis revealed the following: pH 7.46, carbon diox-
ide 35.5mmHg, partial pressure of oxygen 88.6mmHg,
and bicarbonate 26.0mEq/L (room air). Her chest radio-
graph and ECG were normal. A CT angiogram revealed
thrombi of her bilateral pulmonary arteries and left
common iliac vein (Figure 1). Presumably, the pulmonary
thrombosis originated from the thrombi of the left
iliac vein.
Treatment of thrombosis was initiated with intravenous
administration of heparin and urokinase. First, 18IU/kg
of heparin per hour was initiated while adjusting the
dose to maintain APTT between 60 and 85 seconds,
thereafter, urokinase was infused at 10,000U/hour for
24 hours. Oral warfarin administration was also started,
aiming at a prothrombin time-international normalized
ratio of between 1.5 and 2.5, and heparin infusion was
gradually decreased. An inferior vena cava (IVC) filter
was placed percutaneously to avoid further development
of pulmonary thrombosis by the left common iliac vein
thrombi. Furthermore, corticosteroid therapy was initiated
with prednisolone at a dose of 0.8mg/kg per day. Con-
trast-enhanced CT performed on day 14 revealed a reduc-
tion of the pulmonary thrombi and capture of the thrombi
in the inferior vena cava (IVC) filter (Figure 2). The
patient’s proteinuria resolved after 3 weeks of treatment.
The prompt and complete response to the corticosteroid
therapy suggested that minimal change disease was the
etiology of NS and pulmonary artery thrombosis.Discussion
A higher risk of thromboembolism, both arterial and
venous, has been reported in patients with NS [7]. It has
also been reported that the magnitudes of proteinuria
and hypoalbuminemia are related to venous thrombo-
embolism, including pulmonary artery thrombosis, whereas
a glomerular filtration rate test and multiple classic risk
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the less frequent arterial thromboembolism [7].
The association between NS and thromboembolism
was suggested in the literature as early as 1840 [8],
however, the pathophysiology of thromboembolism in
NS has not yet been clearly elucidated. Various hema-
tological changes occur in NS and are related to inci-
dences of thromboembolism [1,9]. In addition, the use
of corticosteroids, immunosuppressants and diuretics
have been suggested to be involved, whereas some studies
have reported the antithrombotic effect of antiproteinuric
therapies [10].
NS is associated with an increased protein synthesis
rate in the liver, counterbalancing the urinary protein
loss [1]. The shortage of several small molecular-size
proteins remains because of the massive urinary loss. By
contrast, the large molecular-size proteins escape the
urinary loss and they are prominently increased because
the increase in protein synthesis is generally nonselective.
Some of the important changes include decreased an-
tithrombin III and protein C, which have anticoagulant
effects, whereas some of the procoagulant factors such
as fibrinogen, factor V and factor VIII are prominently
increased [1,9]. Nevertheless, a clear molecular target
for the prophylaxis has not yet been identified, and there
is insufficient evidence to support the use of routine
prophylactic anticoagulation therapy for all the patients
with NS. The appropriate treatment and the prophylaxis
for pulmonary artery thrombosis with NS are still under
discussion because of the lack of large, prospective ran-
domized trials.
Previous case reports of pulmonary artery thrombosis
complicated with NS are very rare, particularly in adults.
Presumably, this is largely because of the fact that
thromboembolism is a common complication of NS for
nephrologists. In the very rare cases that do occur, the
patients initially complain of the symptoms derived from
pulmonary artery thrombosis [2-4]. Palpitations or chest
discomfort without obvious abnormality in ECG or chest
radiograph particularly in young patients may not be
regarded as serious. In fact, McPheeters et al. reported
a case of 10-year-old boy with pulmonary artery throm-
bosis who died [6]. He had been treated for NS, and
consulted an emergency room with a complaint of
shortness of breath. After being stable on observation
for several hours, he went home; however, he shortly
returned to the hospital and died.
In our case, the patient was predisposed to a pro-
thrombotic state because of severe hypoalbuminemia
and hypercholesterolemia along with low levels of anti-
thrombin III and protein C. She did not have any other
prothrombotic risk factors, nor did she have symptoms
which suggest collagen diseases such as systemic lupus
erythematosus. She had been aware of the edema of thelower extremities for 2 weeks, however, her chief com-
plaints on visiting the physician were palpitations and
chest pain, which derived from pulmonary artery throm-
bosis. Although the first and the second physicians
whom she consulted did recognize the possibility of
NS, a CT was not performed until she visited a third
physician in the emergency department 2 days later.
Therefore the awareness of the complication of pulmonary
artery embolism in NS is important not only for ne-
phrologists but also for all other clinicians, particularly
in primary care clinics or emergency rooms.
As previously reported [9,11,12], we successfully treated
this case with urokinase, heparin, warfarin, and an IVC
filter. The administration of urokinase in patients with
stable hemodynamic variables is still controversial because
of the risk of bleeding. Nevertheless, there was a sig-
nificant risk of a recurrent thromboembolic event in
this patient; in fact, the capture of the thrombus in the
IVC filter indicated that the treatment was effective.
Further investigation is necessary to clearly elucidate the
appropriate treatment and prophylaxis for thromboembol-
ism in patients with NS.
Conclusions
In summary, we describe a case of a 21-year-old Japanese
woman who presented with pulmonary artery thrombosis
and was diagnosed with NS. The awareness of the compli-
cation of pulmonary artery embolism in NS is important
not only for nephrologists but also for all other clinicians.
Contrast-enhanced CT is essential for the diagnosis of
pulmonary artery thrombosis.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IN and MS prepared the manuscript and performed the literature search. HY,
NN and KO revised the manuscript. IN, RM, YS and TF treated the patient. All
authors read and approved the final manuscript.
Author details
1Department of Cardiology, Respiratory Medicine and Nephrology, Hirosaki
University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki
036-8562, Japan. 2Community Medicine, Hirosaki University Graduate School
of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan.
Received: 18 March 2013 Accepted: 25 July 2013
Published: 23 August 2013
References
1. Kerlin BA, Ayoob R, Smoyer WE: Epidemiology and pathophysiology of
nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc
Nephrol 2012, 7(3):513–520.
Narita et al. Journal of Medical Case Reports 2013, 7:215 Page 4 of 4
http://www.jmedicalcasereports.com/content/7/1/2152. Goldhaber SZ: Pulmonary embolism. N Eng J Med 1998, 339(2):93–104.
3. Ahmed K, Saeed E: Nephrotic syndrome and pulmonary artery
thrombosis. Am J Nephrol 1995, 15(3):274–276.
4. Kao SC, Tsai CJ, Shieh WB, Wu MS: Adult minimal change disease
presenting with bilateral pulmonary artery thrombosis―a reversible
complication. Nephrol Dial Transplant 1996, 11(12):2485–2488.
5. Peces R, Pobes A, Rodriguez M, Navascues RA, Ortega F, Alvarez-Grande J:
Multiple venous thrombosis and massive pulmonary artery thrombus as
the presenting features of steroid-responsive nephrotic syndrome.
Nephrol Dial Transplant 1999, 14(5):1306–1309.
6. McPheeters RA, Purcell TB, Snyder DL, Peterson RT: Fatal pulmonary
embolism in a 10-year old with nephrotic syndrome. California J Emerg
Med 2003, 4(2):36–38.
7. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L,
Navis G, van der Meer J: High absolute risks and predictors of venous and
arterial thromboembolic events in patients with nephrotic syndrome:
results from a large retrospective cohort study. Circulation 2008,
117(2):224–230.
8. Royer PFO: Traine’ des maladies des reins et des alterations de la se’cre’tion
urinaire, Volume 2. Paris: Bailliere; 1840:590.
9. Orth SR, Ritz E: The nephrotic syndrome. N Eng J Med 1998,
338(17):1202–1211.
10. Mahmoodi BK, Mulder AB, Waanders F, Spronk HM, Mulder R, Slagman MC,
Vogt L, Navis G, Ten cate H, Kluin-Nelemans HC, Laverman GD: The impact
of antiproteinuric therapy on the prothrombotic state in patients with
overt proteinuria. J Thromb Haemost 2011, 9(12):2416–2423.
11. Beaufils F, Schlegel N, Loirat C, Marotte R, Pillion G, Mathieu H: Urokinase
treatment of pulmonary artery thrombosis complicating the pediatric
nephrotic syndrome. Crit Care Med 1985, 13(2):132–134.
12. Tsai YC, Hsieh YK, Lee CT: Inferior vena cava filter as a preventive device
for recurrent pulmonary embolism in a patient with nephrotic
syndrome. Med Prin Pract 2007, 16(4):321–323.
doi:10.1186/1752-1947-7-215
Cite this article as: Narita et al.: An adult case of nephrotic syndrome
presenting with pulmonary artery thrombosis: a case report. Journal of
Medical Case Reports 2013 7:215.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
